PuSH - Publication Server of Helmholtz Zentrum München

Pandit, K.V.* ; Corcoran, D.* ; Yousef, H.* ; Yarlagadda, M.* ; Tzouvelekis, A.* ; Gibson, K.F.* ; Konishi, K.* ; Yousem, S.A.* ; Singh, M.* ; Handley, D.* ; Richards, T.* ; Selman, M.* ; Watkins, S.C.* ; Pardo, A.* ; Ben-Yehudah, A.* ; Bouros, D.* ; Eickelberg, O. ; Ray, P.* ; Benos, P.V.* ; Kaminski, N.*

Inhibition and role of let-7d in idiopathic pulmonary fibrosis.

Am. J. Respir. Crit. Care Med. 182, 220-229 (2010)
DOI
Open Access Green as soon as Postprint is submitted to ZB.
RATIONALE: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and usually lethal fibrotic lung disease characterized by profound changes in epithelial cell phenotype and fibroblast proliferation. OBJECTIVES: To determine changes in expression and role of microRNAs in IPF. METHODS: RNA from 10 control and 10 IPF tissues was hybridized on Agilent microRNA microarrays and results were confirmed by quantitative real-time polymerase chain reaction and in situ hybridization. SMAD3 binding to the let-7d promoter was confirmed by chromatin immunoprecipitation, electrophoretic mobility shift assay, luciferase assays, and reduced expression of let-7d in response to transforming growth factor-beta. HMGA2, a let-7d target, was localized by immunohistochemistry. In mice, let-7d was inhibited by intratracheal administration of a let-7d antagomir and its effects were determined by immunohistochemistry, immunofluorescence, quantitative real-time polymerase chain reaction, and morphometry. Measurements and Main RESULTS: Eighteen microRNAs including let-7d were significantly decreased in IPF. Transforming growth factor-beta down-regulated let-7d expression, and SMAD3 binding to the let-7d promoter was demonstrated. Inhibition of let-7d caused increases in mesenchymal markers N-cadherin-2, vimentin, and alpha-smooth muscle actin (ACTA2) as well as HMGA2 in multiple epithelial cell lines. let-7d was significantly reduced in IPF lungs and the number of epithelial cells expressing let-7d correlated with pulmonary functions. HMGA2 was increased in alveolar epithelial cells of IPF lungs. let-7d inhibition in vivo caused alveolar septal thickening and increases in collagen, ACTA2, and S100A4 expression in SFTPC (pulmonary-associated surfactant protein C) expressing alveolar epithelial cells. CONCLUSIONS: Our results indicate a role for microRNAs in IPF. The down-regulation of let-7d in IPF and the profibrotic effects of this down-regulation in vitro and in vivo suggest a key regulatory role for this microRNA in preventing lung fibrosis. Clinical trial registered with www.clinicaltrials.gov (NCT 00258544).
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords epithelial-mesenchymal transition; HMGA2 (high-mobility group AT-hook 2); microRNA; transforming growth factor-beta
ISSN (print) / ISBN 1073-449X
e-ISSN 1535-4970
Quellenangaben Volume: 182, Issue: 2, Pages: 220-229 Article Number: , Supplement: ,
Publisher American Thoracic Society
Reviewing status Peer reviewed